Suppr超能文献

[基于脉搏指示连续心输出量监测(PiCCO)的脓毒症拯救集束化治疗对感染性休克患者的临床研究]

[Clinical studies of surviving sepsis bundles according to PiCCO on septic shock patients].

作者信息

Lu Nianfang, Zheng Ruiqiang, Lin Hua, Shao Jun, Yu Jiangquan

机构信息

Department of Intensive Care Unit, Subei People's Hospital of Jiangsu Province and Clinical Medical School of Yangzhou University, Yangzhou 225001, Jiangsu, China. Corresponding author: Zheng Ruiqiang, Email:

出版信息

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014 Jan;26(1):23-7. doi: 10.3760/cma.j.issn.2095-4352.2014.01.005.

Abstract

OBJECTIVE

To explore the effect of early goal-directed therapy (EGDT) according to pulse indicated continuous cardiac output (PiCCO) on septic shock patients.

METHODS

Eighty-two septic shock patients in Subei People's Hospital of Jiangsu Province from January 2009 to December 2012 were enrolled and randomly divided into two groups using a random number table, standard surviving sepsis bundle group (n=40) and modified surviving sepsis bundles group (n=42). The patients received the standard EGDT bundles in standard surviving sepsis bundle group. PiCCO catheter was placed in modified surviving sepsis bundles group. Fluid resuscitation was guided by intrathoracic blood volume index (ITBVI) with the aim of 850-1 000 mL/m(2). Dobutamine was used to improve the heart function according to left ventricular contractile index (dPmax) and stroke volume index (SVI). The mean arterial blood pressure (MAP) was maintained 65 mmHg (1 mmHg=0.133 kPa) or above with norepinephrine. Extra-vascular lung water was monitored for the titration of liquid and diuretics. The acute physiology and chronic health evaluation II (APACHEII) score, sequential organ failure assessment (SOFA) score, the number of patients needed vasopressor, serum procalcitonin (PCT), lactic acid and lactate extraction ratio, the amount of fluid resuscitation, duration of mechanical ventilation, duration of intensive care unit (ICU) stay, hospital mortality were recorded in both groups.

RESULTS

After treatment, the APACHEII score, SOFA score and the number of patients needed vasopressor were gradually reduced in both groups, and those in modified surviving sepsis bundle group were significantly lower than those of standard sepsis bundle group at 72 hours (APACHEII score: 13.1±6.5 vs. 20.9±7.5, SOFA score: 8.8±4.3 vs. 14.6±4.9, the number of patients needed vasopressor: 8 vs. 17, all P<0.05). Arterial blood lactate clearance rate was gradually increased after treatment in both groups. Lactate clearance rate in modified surviving sepsis bundle group was significantly higher than that of standard surviving sepsis bundle group [6 hours: (18.2±8.3)% vs. (10.8±7.5)%, t=-6.036, P=0.001; 12 hours: (22.6±7.3)% vs. (12.4±8.1)%, t=-4.536, P=0.001; 24 hours: (27.8±5.6)% vs. (16.4±9.5)%, t=-5.882, P=0.000]. The amount of fluid resuscitation within 6 hours in modified surviving sepsis bundle group increased significantly compared with standard surviving sepsis bundle group (3 608±715 mL vs. 2 809±795 mL, t=-3.865, P=0.033). The amount of fluid resuscitation within 24, 48 and 72 hours in modified surviving sepsis bundle group was significantly less than that of standard modified surviving sepsis bundle group with the nadir at 72 hours (918±351 mL vs. 1 805±420 mL, t=5.907, P=0.037). Duration of mechanical ventilation (98.4±20.3 hours vs. 143.3±29.6 hours, t=9.766, P=0.001) and ICU stay (7.1±3.1 days vs. 9.5±2.5 days, t=2.993, P=0.004) were significantly reduced in modified surviving sepsis bundle group compared with standard surviving sepsis bundle group. The hospital mortality in modified surviving sepsis bundle group was slightly lower than that in standard surviving sepsis bundle group [16.7% (7/42) vs. 17.5%(7/40), χ (2)=0.010, P=0.920].

CONCLUSIONS

Modified surviving sepsis bundle treatment according PiCCO can reduce the severity of disease in patients with septic shock, can make more accurately guide fluid resuscitation, and can reduce lung water and duration of mechanical ventilation and ICU stay. It has great clinical significance.

摘要

目的

探讨基于脉搏指示连续心输出量(PiCCO)的早期目标导向治疗(EGDT)对感染性休克患者的影响。

方法

选取2009年1月至2012年12月在江苏省苏北人民医院就诊的82例感染性休克患者,采用随机数字表法将其随机分为两组,即标准脓毒症存活集束治疗组(n = 40)和改良脓毒症存活集束治疗组(n = 42)。标准脓毒症存活集束治疗组患者接受标准EGDT集束治疗。改良脓毒症存活集束治疗组置入PiCCO导管。以胸腔内血容量指数(ITBVI)指导液体复苏,目标值为850 - 1 000 mL/m²。根据左心室收缩指数(dPmax)和每搏量指数(SVI)使用多巴酚丁胺改善心功能。使用去甲肾上腺素将平均动脉压(MAP)维持在65 mmHg(1 mmHg = 0.133 kPa)及以上。监测血管外肺水以滴定液体和利尿剂的用量。记录两组患者的急性生理与慢性健康状况评分系统II(APACHEII)评分、序贯器官衰竭评估(SOFA)评分、需要血管活性药物支持的患者数量、血清降钙素原(PCT)、乳酸及乳酸清除率、液体复苏量、机械通气时间、重症监护病房(ICU)住院时间、医院死亡率。

结果

治疗后,两组患者的APACHEII评分、SOFA评分及需要血管活性药物支持的患者数量均逐渐降低,且改良脓毒症存活集束治疗组在72小时时上述指标均显著低于标准脓毒症存活集束治疗组(APACHEII评分:13.1±6.5 vs. 20.9±7.5,SOFA评分:8.8±4.3 vs. 14.6±4.9,需要血管活性药物支持的患者数量:8 vs. 17,均P < 0.05)。两组患者治疗后动脉血乳酸清除率均逐渐升高。改良脓毒症存活集束治疗组乳酸清除率显著高于标准脓毒症存活集束治疗组[6小时:(18.2±8.3)% vs. (10.8±7.5)%,t = -6.036,P = 0.001;12小时:(22.6±7.3)% vs. (12.4±8.1)%,t = -4.536,P = 0.001;24小时:(27.8±5.6)% vs. (16.4±9.5)%,t = -5.882,P = 0.000]。改良脓毒症存活集束治疗组6小时内的液体复苏量较标准脓毒症存活集束治疗组显著增加(3 608±715 mL vs. 2 809±795 mL,t = -3.865,P = 0.033)。改良脓毒症存活集束治疗组24小时、48小时及72小时的液体复苏量显著少于标准脓毒症存活集束治疗组,72小时时达到最低值(918±351 mL vs. 1 805±420 mL,t = 5.907,P = 0.037)。改良脓毒症存活集束治疗组的机械通气时间(98.4±20.3小时 vs. 143.3±29.6小时,t = 9.766,P = 0.001)和ICU住院时间(7.1±3.1天 vs. 9.5±2.5天,t = 2.993,P = 0.004)较标准脓毒症存活集束治疗组显著缩短。改良脓毒症存活集束治疗组的医院死亡率略低于标准脓毒症存活集束治疗组[16.7%(7/42)vs. 17.5%(7/40),χ² = 0.010,P = 0.920]。

结论

基于PiCCO的改良脓毒症存活集束治疗可降低感染性休克患者的疾病严重程度,能更精准地指导液体复苏,可减少肺水以及机械通气时间和ICU住院时间,具有重要的临床意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验